Cardiac Amyloidosis Registry Study

Enrolling by invitationOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Amyloidosis, Immunoglobulin Light-chain
Interventions
OTHER

Registry

Observational, data collection

Trial Locations (23)

10016

NYU Langone Health, New York

10021

Weill Cornell Medicine, New York

10029

The Mount Sinai Hospital, New York

10032

Columbia University Irving Medical Center, Clinical Cardiovascular Research Laboratory for the Elderly (CUMC/CCRLE), New York

19104

Penn Presbyterian Medical Center, Philadelphia

20010

MedStar Health and Vascular Institute/Georgetown University School of Medicine, Washington D.C.

21287

Johns Hopkins University School of Medicine, Baltimore

27710

Duke Health, Durham

29425

Medical University of South Carolina, Charleston

63110

Washington University in St. Louis, St Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

75390

University of Texas Southwestern Medical Center, Dallas

77030

University of Texas Health Science Center at Houston, Houston

84112

University of Utah, Salt Lake City

85724

University of Arizona Sarver Heart Center, Tucson

92037

UC San Diego Health, Sulpizio Cardiovascular Center, La Jolla

92137

Scripps Health, La Jolla

94103

University of California, San Francisco, San Francisco

95817

University of California Davis, Sacramento

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02118

Boston Medical Center, Boston

T2N 4Z6

University of Calgary, Calgary

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER